PNT News and Press, POINT Biopharma Global Inc. From 05/04/23

NORTHAMPTON, MA / ACCESSWIRE / May 4, 2023 / Pentair Karla Robertson highlighted the positive impacts made in 2022 during Pentair's Global Town Hall in May 2023. As published on the Pentair Blog By Karla Robertson, Pentair Executive Vice President, General Counsel, Secretary, and Chief...

2023-05-04 15:43:07 ET Summary Today, we circle back on Lantheus Holdings, Inc., a midcap radiology diagnostic company that is turning into a sales growth juggernaut. The company reported stellar quarterly results once again this morning for Q1 2023 and raised guidance significant...

BEDFORD, Mass. and INDIANAPOLIS, April 24, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find...

BEDFORD, Mass. and INDIANAPOLIS, April 24, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fig...

LONDON, UK / ACCESSWIRE / April 18, 2023 / Pentair, (NYSE:PNR) a leader in helping the world sustainably move, improve and enjoy water, life's most essential resource, today released its 2022 Corporate Responsibility Report, reporting on the Company's efforts toward Making Better Essential thr...

2023-04-05 13:40:01 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips While it might be difficult to navigate the equities sector now amid various headwinds, biotech stocks to buy may offer a surprising respite. True, the market presence of the surprise produ...

BERLIN and INDIANAPOLIS, April 04, 2023 (GLOBE NEWSWIRE) -- Eckert & Ziegler (ISIN DE0005659700, TecDAX) and a subsidiary of POINT Biopharma Global Inc. (“POINT”, NASDAQ: PNT) have signed an agreement on the supply of Actinium-225 (non-carrier-added Ac-225). Eckert & Ziegler...

LONDON, UK / ACCESSWIRE / March 29, 2023 / Pentair (NYSE:PNR), a leading provider of water treatment and sustainable solutions, is proud to announce it received the 2023 ENERGY STAR ® Partner of the Year - Sustained Excellence Award from the U.S. Environmental Protection Agency (EPA) and t...

2023-03-27 09:41:17 ET POINT Biopharma Global press release ( NASDAQ: PNT ): Q4 GAAP EPS of $1.53. Revenue of $226.58M. Cash, cash equivalents and investments were $541.3 million as of December 31, 2022, For further details see: POINT Biopharma Global GAAP EP...

Signed Strategic Collaboration Agreement with Lantheus Holdings Inc. for POINT's PNT2002 and PNT2003 product candidates Completed enrollment for randomization phase of PNT2002's phase 3 SPLASH registrational trial, with top line data expected in the second half of 2023 INDIANA...